Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Current Deferred Revenue: 2017-2019

Historic Current Deferred Revenue for Cogent Biosciences (COGT) over the last 3 years, with Dec 2019 value amounting to $1.3 million.

  • Cogent Biosciences' Current Deferred Revenue fell 97.95% to $312,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $312,000, marking a year-over-year decrease of 97.95%. This contributed to the annual value of $1.3 million for FY2019, which is 92.67% down from last year.
  • According to the latest figures from FY2019, Cogent Biosciences' Current Deferred Revenue is $1.3 million, which was down 92.67% from $17.9 million recorded in FY2018.
  • Over the past 5 years, Cogent Biosciences' Current Deferred Revenue peaked at $17.9 million during FY2018, and registered a low of $1.3 million during FY2019.
  • In the last 3 years, Cogent Biosciences' Current Deferred Revenue had a median value of $6.9 million in 2017 and averaged $8.7 million.
  • Per our database at Business Quant, Cogent Biosciences' Current Deferred Revenue spiked by 160.47% in 2018 and then plummeted by 92.67% in 2019.
  • Yearly analysis of 3 years shows Cogent Biosciences' Current Deferred Revenue stood at $6.9 million in 2017, then soared by 160.47% to $17.9 million in 2018, then slumped by 92.67% to $1.3 million in 2019.